BSc, (hons), Biomedical Science
The University of Manchester, Manchester, United Kingdom
Matthew Lyall, BSc, works as a Health Outcomes Scientist at RTI HS in the Manchester office. Mr. Lyall joined RTI-HS as an intern and prior to joining RTI-HS, he completed an honors Bachelors of Science degree in Biomedical Sciences. While getting his degree, Mr. Lyall completed a lab-based research project in the Manchester Collaborative Centre for Inflammation Research where he contributed to cutting edge research into how the inflammatory process is regulated. Mr. Lyall has experience in contributing to systematic and targeted literature reviews, evidence-based value dossiers, slide sets, communication packages, and manuscripts. Mr. Lyall also has broad experience in health technology assessments in a range of countries including submissions to NICE, the NCPE, the SMC, NoMA, the DMC Denmark and the TLV. Mr. Lyall has been involved in projects in a range of therapeutic areas, including oncology, diabetes, age related macular degeneration, asthma, multiple sclerosis, Alzheimer’s disease, cytomegalovirus infection, COVID-19, and Duchenne muscular dystrophy.